We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$17.1B
AUM Growth
+$3.66B
Cap. Flow
+$3.21B
Cap. Flow %
18.8%
Top 10 Hldgs %
17.19%
Holding
3,910
New
1,049
Increased
1,025
Reduced
895
Closed
871

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.17B
2
QQQ icon
Invesco QQQ Trust
QQQ
+$147M
3
MSFT icon
Microsoft
MSFT
+$123M
4
AMZN icon
Amazon
AMZN
+$110M
5
HD icon
Home Depot
HD
+$96.6M

Sector Composition

Rank Sector Weight
1 Technology 11.91%
2 Consumer Discretionary 9.35%
3 Healthcare 6.69%
4 Financials 5.63%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPCO
2451
DELISTED
Tribune Publishing Company Common Stock
TPCO
$284K ﹤0.01%
+15,805
New +$256K
INVE icon
2452
Identive
INVE
$64.6M
$283K ﹤0.01%
24,684
+10,738
+77% +$110K
BCPC
2453
Balchem Corp
BCPC
$5.23B
$283K ﹤0.01%
+2,255
New +$274K
MRO
2454
PUT
DELISTED
Marathon Oil Corporation
MRO
$283K ﹤0.01%
+26,500
New +$256K
BKCC
2455
DELISTED
BlackRock Capital Investment Corporation
BKCC
$283K ﹤0.01%
+84,444
New +$268K
BLD
2456
DELISTED
TopBuild
BLD
$282K ﹤0.01%
1,348
+78
+6% +$15.9K
CX icon
2457
Cemex
CX
$17.4B
$282K ﹤0.01%
40,520
-79,246
-66% -$512K
LNTH icon
2458
Lantheus
LNTH
$6.82B
$282K ﹤0.01%
13,215
-7,284
-36% -$132K
RVNC
2459
DELISTED
Revance Therapeutics, Inc.
RVNC
$281K ﹤0.01%
+10,067
New +$278K
CTHR
2460
DELISTED
Charles & Colvard Ltd
CTHR
$280K ﹤0.01%
+9,464
New +$206K
GOSS icon
2461
Gossamer Bio
GOSS
$66.5M
$279K ﹤0.01%
30,188
-23,929
-44% -$241K
RAPT
2462
DELISTED
RAPT Therapeutics
RAPT
$279K ﹤0.01%
1,571
-1,936
-55% -$319K
SLQT icon
2463
SelectQuote
SLQT
$114M
$279K ﹤0.01%
+9,465
New +$248K
DSSI
2464
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
$279K ﹤0.01%
27,800
+2,997
+12% +$24.3K
PMT
2465
PennyMac Mortgage Investment
PMT
$849M
$278K ﹤0.01%
14,173
-8,923
-39% -$165K
EXAS
2466
CALL
DELISTED
Exact Sciences
EXAS
$277K ﹤0.01%
2,100
NBIX icon
2467
Neurocrine Biosciences
NBIX
$17.7B
$277K ﹤0.01%
2,847
-1,197
-30% -$126K
ALLY icon
2468
CALL
Ally Financial
ALLY
$13.1B
$276K ﹤0.01%
+6,100
New +$255K
ADMS
2469
DELISTED
Adamas Pharmaceuticals
ADMS
$276K ﹤0.01%
57,484
+17,662
+44% +$92.2K
RNAM
2470
DELISTED
Avidity Biosciences
RNAM
$275K ﹤0.01%
12,616
+2,843
+29% +$69.6K
EQNR icon
2471
Equinor
EQNR
$95.9B
$274K ﹤0.01%
14,091
-26,602
-65% -$505K
GRVY
2472
GRAVITY
GRVY
$427M
$274K ﹤0.01%
+2,384
New +$370K
CIR
2473
DELISTED
CIRCOR International, Inc
CIR
$274K ﹤0.01%
+7,877
New +$283K
SAFE
2474
DELISTED
Safehold Inc.
SAFE
$274K ﹤0.01%
+3,908
New +$295K
GERN icon
2475
Geron
GERN
$911M
$273K ﹤0.01%
+172,772
New +$309K

Similar funds

Squarepoint's Q1 2021 Portfolio in Review

As of Q1 2021, Squarepoint held 3,910 positions worth $17.1B, up 27% from $13.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Squarepoint deployed $3.21B of net new capital in Q1 2021, opening 1,049 new positions and adding to 1,025 existing holdings. Its largest new stake was Block Inc: 215,753 shares worth $49M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $1.17B trimmed.

  • Squarepoint's largest Q1 2021 buy was Block Inc: 215,753 shares worth $49M.
  • Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $342M increase.
  • Squarepoint's biggest Q1 2021 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.17B.
  • Squarepoint fully exited Home Depot in Q1 2021, selling an estimated $96.6M.
  • Squarepoint's ten largest holdings make up 17% of its $17.1B portfolio in Q1 2021.
  • Squarepoint opened 1,049 new positions and closed 871 in Q1 2021.
  • Squarepoint's portfolio value rose 27% quarter-over-quarter to $17.1B.

Based on Squarepoint's 13F filing for Q1 2021, filed 17 May 2021.